Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel
Status:
Active, not recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
Objective: To assess the safety and tolerability of the PRO-165 formulation on the ocular
surface of ophthalmologically and clinically healthy subjects.
Hypothesis: Ophthalmic gel PRO-165 presents a safety and tolerability profile similar to
Artelac® Nightime Gel in ophthalmological and clinically healthy subjects.
Phase I clinical study, controlled, of parallel groups, double blind, randomized, exploratory
Therapeutic indication of PRO-165: Eye lubricant